Academic
Publications
Review of cryptogenic fibrosing alveolitis, including current treatment guidelines

Review of cryptogenic fibrosing alveolitis, including current treatment guidelines,10.1136/pmj.76.900.618,Postgraduate Medical Journal,Stephen C Bourk

Review of cryptogenic fibrosing alveolitis, including current treatment guidelines   (Citations: 2)
BibTex | RIS | RefWorks Download
Journal: Postgraduate Medical Journal - POSTGRAD MED J , vol. 76, no. 900, pp. 618-624, 2000
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...Patients with IPF/CFA not infrequently have a positive rheumatoid factor (19%) or antinuclear factor (26%) in the serum and B-lymphocyte aggregates on lung histology, suggesting that an immunological derangement may be involved [5, 6]. As these autoantibodies are non-organ specific, they are considered epiphenomenal, representing a secondary feature of tissue damage induced by some other mechanisms [86]...
    • ...The greater utility of DTPA scanning could lie in its potential ability to predict disease progression [101], but probably only in non-smokers as smoking will also increase DTPA clearance [6]...
    • ...Current approaches have been recently reviewed [1, 5, 6, 123, 125, 126]...

    J. M. Fellrathet al. Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis

Sort by: